Chemosensitivity of a novel Akt inhibitor, MK2206, in gastric cancer cell lines

被引：0
|
作者：
Kim, Hyosong [1 ]
Kim, Tae Soo [1 ]
Kwan, Bo Ram [1 ]
Kim, Jeong Min [1 ]
Park, Chan Hee Park [1 ]
Jeung, Hei-Cheul [1 ]
Ahn, Joong-Bae [1 ]
Shin, Sang-Joon [1 ]
Chung, Hyun Cheol [1 ]
Rha, Sun Young [1 ]
机构：
[1] Yonsei Canc Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-1986
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1986
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
    Ravi S. Narayan
    Carlos A. Fedrigo
    Eelke Brands
    Rogier Dik
    Lukas J.A. Stalpers
    Brigitta G. Baumert
    Ben J. Slotman
    Bart A. Westerman
    Godefridus J. Peters
    Peter Sminia
    BMC Cancer, 17
  • [22] Biomarkers of response to Akt inhibitor MK-2206 in breast cancer
    Sangai, Takafumi
    Akcakanat, Argun
    Chen, Huiqin
    Tarco, Emily
    Wu, Yun
    Do, Kim-Anh
    Miller, Todd W.
    Arteaga, Carlos L.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana M.
    Meric-Bernstam, Funda
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
    Sangai, Takafumi
    Akcakanat, Argun
    Chen, Huiqin
    Tarco, Emily
    Wu, Yun
    Do, Kim-Anh
    Miller, Todd W.
    Arteaga, Carlos L.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana Maria
    Meric-Bernstam, Funda
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5816 - 5828
  • [24] The Effect of MK-2206, a New AKT Inhibitor on the Gastric Cancer Cells Growth and Enhancement of Chemotherapy
    Jin, Piaopiao
    Cheng, Jianfeng
    Sun, Leimin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S41 - S41
  • [25] Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infection In Vitro
    Denisova, Oxana V.
    Soderholm, Sandra
    Virtanen, Salla
    Von Schantz, Carina
    Bychkov, Dmitrii
    Vashchinkina, Elena
    Desloovere, Jens
    Tynell, Janne
    Ikonen, Niina
    Theisen, Linda L.
    Nyman, Tuula A.
    Matikainen, Sampsa
    Kallioniemi, Olli
    Julkunen, Ilkka
    Muller, Claude P.
    Saelens, Xavier
    Verkhusha, Vladislav V.
    Kainov, Denis E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3689 - 3696
  • [26] Effects Of An Allosteric AKT Inhibitor (MK2206) Administered With Or Without The Aromatase Inhibitor Vorozole In An ER+ Rat Mammary Cancer Model: Preventive And Therapeutic Effects
    Lubet, R. A.
    Ellis, M. J.
    Grubbs, C. J.
    CANCER RESEARCH, 2012, 72
  • [27] Antitumor activity of novel Akt inhibitor, perifosine in gastric cancer cell lines
    Kim, Tae Soo
    Kim, Hyo Song
    Kwan, Bo Ram
    Park, Chan Hee Park
    Jeung, Hei-Cheul Jeung
    Jang, Woo Ick
    Enge, Juergen
    Chung, Hyun Cheol
    Roh, Jae Kyung
    Rha, Sun Young
    CANCER RESEARCH, 2011, 71
  • [28] Bufalin Enhances the Cytotoxity of Human Multiple Myeloma Cells H929 to AKT Inhibitor MK2206: The Role of Protein AKT Phosphorylation
    He Huang
    Xiao-ji Lin
    Ying Lin
    Ron-xin Yao
    Mu-qing He
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 268 - 272
  • [29] MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
    Ru-Fang Xiang
    Yan Wang
    Nan Zhang
    Wen-Bin Xu
    Yang Cao
    Jia Tong
    Jun-min Li
    Ying-Li Wu
    Hua Yan
    Cell Death & Disease, 2017, 8 : e2776 - e2776
  • [30] Akt inhibitor MK-2206 reduces pancreatic cancer cell viability and increases the efficacy of gemcitabine
    Wang, Zhanshan
    Luo, Guangtao
    Qiu, Zhengjun
    ONCOLOGY LETTERS, 2020, 19 (03) : 1999 - 2004
12345